Risk factors for relapse in patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant: a real-world analysis in Germany and the United Kingdom.
Authors
Zagadailov, ECorman, S
Hagan, M
Chirikov, V
Johnson, C
Macahilig, C
Seal, B
Dalal, M
Illidge, Timothy M
Brockelmann, P J
Affiliation
Millennium Pharmaceuticals, Inc., Cambridge, MA, USAIssue Date
2016